“…The unique properties of this MOF stimulated the development of flexible ZIF-8-based platforms for the drug delivery of small-molecule and macromolecular therapeutics [ 9 ]. ZIF-8 exhibits pH-controllable drug release, high efficiency of endosomal escape, and good biocompatibility [ 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 ]. The surface of ZIF-8 particles is modifiable by targeting agents, providing a higher efficiency of nanoparticle-based therapy [ 19 , 20 , 21 ].…”